(Q30557454)

English

The efficacy of dapagliflozin combined with hypoglycemic drugs in treating type 2 diabetes: protocol for meta-analysis of randomized controlled trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

1 reference

based on heuristic

inferred from title

The efficacy of dapagliflozin combined with hypoglycemic drugs in treating type 2 diabetes: protocol for meta-analysis of randomized controlled trials (English)

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

author name string

Yu-Nan Sun

1

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

Yi Zhou

2

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

Xi Chen

3

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

Wen-Si Che

4

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

Siu-Wai Leung

5

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

13 November 2013

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

Systematic Reviews

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

2

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

103

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

https://scigraph.springernature.com/pub.10.1186/2046-4053-2-103

0 references

Dapagliflozin treatment for type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3833641

20 June 2018

Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3833641

20 June 2018

Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3833641

20 June 2018

Dapagliflozin: a sodium glucose cotransporter 2 inhibitor in development for type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3833641

20 June 2018

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3833641

20 June 2018

A novel approach to control hyperglycemia in type 2 diabetes: sodium glucose co-transport (SGLT) inhibitors: systematic review and meta-analysis of randomized trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3833641

20 June 2018

Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3833641

20 June 2018

SGLT2 inhibition--a novel strategy for diabetes treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3833641

20 June 2018

Management of blood glucose in type 2 diabetes mellitus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3833641

20 June 2018

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3833641

20 June 2018

Islet beta cell failure in type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3833641

20 June 2018

Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3833641

20 June 2018

Evaluation of risk factors for development of complications in Type II diabetes in Europe

1 reference

https://api.crossref.org/works/10.1186%2F2046-4053-2-103

21 January 2018

Conducting Meta-Analyses in R with the metafor Package

1 reference

https://api.crossref.org/works/10.1186%2F2046-4053-2-103

21 January 2018

Identifiers

10.1186/2046-4053-2-103

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30557454&oldid=1957733379"